图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
真核基因表达评论综述™
影响因子: 1.734 5年影响因子: 1.848 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN 打印: 1045-4403
ISSN 在线: 2162-6502

真核基因表达评论综述™

DOI: 10.1615/CritRevEukaryotGeneExpr.2018025847
pages 321-327

The Mechanisms of Dietary Phytoestrogen as a Potential Treatment and Prevention Agent against Alzheimer’s Disease

Azhar Hussain
Davenport University School of Business and Management; Xavier University School of Medicine, Woodbury, New York
Elsa S. Tabrez
St. Matthew's University School of Medicine, George Town, Cayman Islands
Adil Muhammad
University of Texas at Dallas, Dallas, Texas
Jagannadha Rao Peela
St. Matthew's University, School of Medicine, Grand Cayman, Cayman Islands

ABSTRACT

Alzheimer's disease (AD) is a major dementia disease worldwide with an increasing incidence rate among the elderly. It is a neurodegenerative disease with symptoms starting slowly and then progressing over time. There has been extensive research on AD prevention and treatment; however, there is no cure as of yet. Several drugs are being researched for the treatment and prevention of AD, with a rising interest in specific dietary compounds as potential interventions with lower side effects. One such dietary compound being tested is phytoestrogen. Phytoestrogens are chemically, structurally, and functionally similar to estrogen, which has numerous functions as a cognition-promoting agent; although, as a supplement it can be damaging. Phytoestrogens have the unique ability to substitute for estrogen in elderly individuals with Alzheimer's disease and depleted estrogen levels. This paper aims to contribute to the collective understanding of phytoestrogen's role in the treatment and prevention of Alzheimer's disease by describing its various mechanisms, including its ability to decrease amyloid beta peptide production, promote calcium outflow and acetylcholine release, and reduce Tau protein phosphorylation. The paper also addresses phytoestrogen's role as an anti-inflammatory and antioxidant agent for the cholinergic neurons associated with Alzheimer's disease.


Articles with similar content:

Immunological and Toxicological Implications of Short-Term Studies in Animals of Pharmaceutical Aerosol Delivery to the Lungs: Relevance to Humans
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.18, 2001, issue 4
Lucila Garcia-Contreras, Anthony J. Hickey
The Agaricoglyceride of Royal Sun Medicinal Mushroom, Agaricus brasiliensis (Higher Basidiomycetes) is Anti-Inflammatory and Reverses Diabetic Glycemia in the Liver of Mice
International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 4
Xu Gao, Yan Sun, Haitao Yu, Xiaodan Qi, Chunchao Han, Chunjing Zhang, Yan Shi
Caffeine: A Potential Protective Agent Against Cognitive Decline in Alzheimer’s Disease
Critical Reviews™ in Eukaryotic Gene Expression, Vol.28, 2018, issue 1
Azhar Hussain, Volodymyr Mavrych, Elsa S. Tabrez, Olena Bolgova, Jagannadha Rao Peela
Critical Review on the Management of Adult Oropharyngeal Dysphagia
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.14, 2002, issue 3&4
Nam-Jong Paik, Tai Ryoon Han
Advances in Buccal Drug Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.22, 2005, issue 3
Raj Birudaraj, Bhaskara R. Jasti, Xiaoling Li, Ravichandran Mahalingam